Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

NCT05953337 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Liver Cancer

Interventions

DEVICE: EYE90 Microspheres Treatment

Sponsor

ABK Biomedical